Skip to content

How It Works Pricing Blog Events Partners

Sign In Get Started →

How It Works Pricing Blog Events Partners

Sign In Get Started →

Loading news...

The OS for early-stage founders from day zero to raise.

Product

How It Works Pricing Partners

Resources

Blog Events Contact

Company

About Privacy Terms

© 2026 Startup Intros, Inc.San Francisco, CA · Made for Founders

ADC Therapeutics - $76M Late Stage Venture | Startup Intros

Home
/News
/ADC Therapeutics - Series E Extension

ADC Therapeutics - $76M Series E Plus

ADC Therapeutics raised $76M Series E Plus venture round.

AnnouncedSeries E PlusLate Stage Venture

Announced: Jun 12, 2019 ·

About Investors Funding History Deep Dive FAQs

Round Details

Date: Jun 12, 2019
Organization: ADC Therapeutics
Amount: $76M
Round: Series E Plus
Status: Announced

Subscribe, Save or Share

Get email updates

Join 25K+ founders & VCs who start their week informed.

About

This funding round does not have an about section yet.

Funding History

This company has completed 8 funding rounds. Current round is highlighted.

Total Raised

$726M

Top Valuation

-

10/13/25$60MVenture RoundLead: TCGX

12/14/20$50MVenture RoundLead: Overland Pharmaceuticals

05/01/20$115MVenture RoundLead: Deerfield Management

06/12/19$76MSeries E Plus

10/23/17$200MVenture RoundLead: AstraZeneca

10/27/16$105MVenture Round

09/02/15$80MVenture Round

10/15/13$40MVenture RoundLead: Michael Forer

Frequently Asked Questions

How much did ADC Therapeutics raise in this round?

ADC Therapeutics raised $76M in a Series E Plus round.

When was the Series E Plus round announced?

The round was announced on 06/12/19.

Deep Dive

Sources

globenewswire.com/en/news-release/2019/06/12/1867429/0/en/adc-therapeutics-announces-completion-of-a-series-e-financing-expansion.html